glp 1 agonists and sglt2 inhibitors combination Full article: inhibitor GLP-1 receptor agonist therapy: a complementary approach to the treatment of type 2 diabetes Glucagon-like peptide 1(GLP-1) receptor agonists
Description
Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes
Exper Qual Stud Sports Med
Transition plan to insulin / discontinuing GLP-1 RA
Additionally, it is recognized that the DPP4 protein, also known as CD26, is involved in the modulation of T cell immune responses [157]
Exenatide: pharmacokinetics, clinical use, and future directions
